linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Medplus Health Services Ltd.
 
Source DateBoard Meeting DateDetails
04 May 202620 May 2026 Audited Results (Revised) & Quarterly Results
30 Mar 202629 May 2026 Quarterly Results & Audited Results
05 Jan 202630 Jan 2026 Quarterly Results
01 Oct 202531 Oct 2025 Quarterly Results
10 Jul 202502 Aug 2025 Quarterly Results
25 Mar 202527 May 2025 Audited Results
08 Jan 202531 Jan 2025 Quarterly Results
10 Oct 202412 Nov 2024 Quarterly Results
27 Jun 202402 Aug 2024 Quarterly Results
01 Apr 202428 May 2024 Audited Results
16 Feb 202421 Feb 2024 Inter alia, to discuss the management recommendation to not proceed with the approval for Qualified Institutional Placement (QIP) received from shareholders on November 30, 2023.
27 Dec 202302 Feb 2024 Quarterly Results
25 Oct 202308 Nov 2023 Quarterly Results (Revised)
18 Oct 202326 Oct 2023 Quarterly Results
06 Oct 202311 Oct 2023 Inter alia, to consider and evaluate proposal for raising of funds by the Company, by way of inter alio, issue of equity shares or any other equity linked instruments or securities including convertible preference shares/ fully or partly convertible debentures or by way of a composite issue of non-convertible debentures and warrants entitling the warrant holder(s) to apply for equity shares, or any other eligible securities through inter alio, a private placement (including one or more qualified institutions placements) or further public issue of equity/ debt securities, preferential issue or a rights issue or through any other permissible mode under applicable laws and/ or combination thereof, as may be considered appropriate, subject to such statutory/regulatory/other approvals as may be required, including the approval of the members, to seek their consent for such fund raising and to approve ancillary actions for such fund raising. The Board, would further convene an Extra-ordinary General Meeting or postal ballot to obtain the approval of shareholders for the above proposal, once approved by the Board.
03 Oct 202305 Oct 2023 Inter alia, to consider and approve the Proposal for raising of funds by the Company
10 Jul 202307 Aug 2023 Quarterly Results (Revised)
07 Jul 202301 Aug 2023 Quarterly Results
03 May 202325 May 2023 Audited Results
25 Apr 202311 May 2023 Inter alia, to consider for approval of Members through Postal Ballot for the following business by way of Special Resolution: i. Approval for extending benefits of Employees Stock Option Plan 2023. to the employees of its Subsidiary Companies; and ii. Alteration of Articles of Association of the Company in relation to retain the Nomination Rights of the Promoters/Investors as per existing Articles of Association of the Company
Page 1 of 2
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.